Yes, Methotrexate Can Be Self-Administered at Home
Methotrexate, used for rheumatoid arthritis, psoriasis, and some cancers, is available in forms patients can inject or take orally themselves after doctor training. Injectable versions come in prefilled syringes or autoinjectors like Otrexup and Rasuvo, designed for weekly subcutaneous self-injection in the thigh or abdomen. Tablets are swallowed daily or weekly without injection.[1]
How Do Patients Self-Inject Methotrexate?
Doctors or nurses demonstrate the process during the first prescription. Steps include:
- Cleaning the site with alcohol.
- Pinching skin, inserting needle at 90 degrees, and injecting slowly.
- Disposing of needles in sharps containers.
Autoinjectors simplify this with one-button activation, hiding the needle. Training videos from manufacturers like Antares Pharma (Otrexup) are available online.[1][2]
What Doses Are Approved for Home Use?
Low-dose oral or subcutaneous methotrexate (7.5-25 mg weekly) is standard for autoimmune conditions and cleared for home use. Higher IV doses for cancer typically require clinic administration due to monitoring needs.[1]
Who Cannot Self-Administer and What Training Is Required?
Children, elderly patients with dexterity issues, or those with vision impairments may need caregiver help. Self-administration requires a prescription with training; it's not started without it. FDA labels mandate patient instructions and risk acknowledgment.[1][3]
Common Side Effects During Home Use
Nausea, fatigue, mouth sores, and liver risks occur; patients monitor via blood tests every 1-3 months. Folic acid supplements reduce side effects. Report severe symptoms like fever or bleeding to a doctor immediately.[1]
Alternatives If Self-Injection Isn't Feasible
Oral methotrexate avoids needles but absorbs less predictably at higher doses. Other self-injectables like Enbrel or Humira treat similar conditions. Infused options like Remicade require clinics.[1]
[1]: FDA Label for Methotrexate Injection
[2]: Otrexup Patient Instructions
[3]: American College of Rheumatology Guidelines